ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. (BMYB34)

308.49
0.00
(0.00%)
Closed February 18 3:55PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
308.49
Bid
297.95
Ask
378.14
Volume
-
0.00 Day's Range 0.00
203.10 52 Week Range 363.51
Market Cap
Previous Close
308.49
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
290
Shares Outstanding
2,028,177,000
Dividend Yield
4.85%
PE Ratio
-12.22
Earnings Per Share (EPS)
-4.41
Revenue
48.3B
Net Profit
-8.95B

About Bristol-Myers Squibb Co.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Bristol-Myers Squibb Co. is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker BMYB34. The last closing price for Bristol-Myers Squibb was R$308.49. Over the last year, Bristol-Myers Squibb shares have traded in a share price range of R$ 203.10 to R$ 363.51.

Bristol-Myers Squibb currently has 2,028,177,000 shares outstanding. The market capitalization of Bristol-Myers Squibb is R$625.67 billion. Bristol-Myers Squibb has a price to earnings ratio (PE ratio) of -12.22.

BMYB34 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-19.2-5.85919619152327.69327.69308.491294319.72419629DR
4-29.82-8.81440099317338.31360308.49480320.03881841DR
12-37.27-10.7791531698345.76363.51308.49290333.15172255DR
2641.7315.6432748538266.76363.51263.9209332.03404241DR
5262.4925.4024390244246363.51203.1474247.57599506DR
156-39.76-11.4170854271348.25431.76203.1433298.96778422DR
26020.87.23000451875287.69431.76203.1525316.70921893DR

BMYB34 - Frequently Asked Questions (FAQ)

What is the current Bristol-Myers Squibb share price?
The current share price of Bristol-Myers Squibb is R$ 308.49
How many Bristol-Myers Squibb shares are in issue?
Bristol-Myers Squibb has 2,028,177,000 shares in issue
What is the market cap of Bristol-Myers Squibb?
The market capitalisation of Bristol-Myers Squibb is BRL 625.67B
What is the 1 year trading range for Bristol-Myers Squibb share price?
Bristol-Myers Squibb has traded in the range of R$ 203.10 to R$ 363.51 during the past year
What is the PE ratio of Bristol-Myers Squibb?
The price to earnings ratio of Bristol-Myers Squibb is -12.22
What is the cash to sales ratio of Bristol-Myers Squibb?
The cash to sales ratio of Bristol-Myers Squibb is 2.26
What is the reporting currency for Bristol-Myers Squibb?
Bristol-Myers Squibb reports financial results in USD
What is the latest annual turnover for Bristol-Myers Squibb?
The latest annual turnover of Bristol-Myers Squibb is USD 48.3B
What is the latest annual profit for Bristol-Myers Squibb?
The latest annual profit of Bristol-Myers Squibb is USD -8.95B
What is the registered address of Bristol-Myers Squibb?
The registered address for Bristol-Myers Squibb is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Bristol-Myers Squibb website address?
The website address for Bristol-Myers Squibb is www.bms.com
Which industry sector does Bristol-Myers Squibb operate in?
Bristol-Myers Squibb operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.20
(53.85%)
192.9k
FRAS3QFras le Sa
R$ 23.00
(27.78%)
1.47M
CTSA4Cia Tecidos Santanense
R$ 0.97
(15.48%)
17.9k
PSVM11PORTO SUDESTE VM SA
R$ 4.84
(15.24%)
500
PTBL3PBG SA
R$ 4.12
(11.65%)
1.24M
CEED3Cia Estadual Distribuicao Energia Eletrica Ceee-d
R$ 11.19
(-19.96%)
800
CASH3Meliuz S.A
R$ 3.36
(-14.50%)
7.78M
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-14.29%)
14.73M
DTCY3Dtcom Direct To Company Sa ex Dtc Direct To Company SA
R$ 3.81
(-11.40%)
100
FICT3Fictor Alimentos S.A.
R$ 4.03
(-10.44%)
110.6k
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0.01
(0.00%)
222.57M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.54
(1.20%)
96.7M
AMOB3Automob Participacoes Sa
R$ 0.28
(3.70%)
51.93M
ITSA4Itausa Investimentos Itau SA
R$ 9.89
(0.815494%)
49.63M
RAIZ4Raizen S.A
R$ 1.85
(4.52%)
49.61M

Discussion

View Full Feed
TheFinalCD TheFinalCD 5 minutes ago
https://x.com/Beppels1/status/1890449070923141202
GCL
The ELTP King The ELTP King 6 minutes ago
Both are happening.

Nasdaq then buyout.

His intention is to suggest with certainty that we are headed for a reverse split and not a buyout.
ELTP
TheFinalCD TheFinalCD 6 minutes ago
GOOD CALL

GLYC BELL BUY INTO VOLUME AND BIG GAPPER
GLYC
Cflores32097 Cflores32097 7 minutes ago
btw FP still owes all those investors he robbed
IDGR
somberfox somberfox 11 minutes ago
30-50 days
CLNV
somberfox somberfox 12 minutes ago
Cawww caww
CLNV
Cflores32097 Cflores32097 12 minutes ago
Oh yea 🦆🦆 is so 2022 we got a new scam
IDGR
Cflores32097 Cflores32097 12 minutes ago
Hey Charles, what happened 🦆 🦆 go
IDGR
Cflores32097 Cflores32097 13 minutes ago
LIONS GROUP CBD EVANS CYBER ZEN
IDGR
Cflores32097 Cflores32097 16 minutes ago
Jzzi CBD HONEY GREG EVANS 55 UP
IDGR
WolfofMia WolfofMia 25 minutes ago
You don't have the energy, except for pompous reasons.

Got it.
AVXL
longview1 longview1 26 minutes ago
My post keep getting removed, obviously making one of the Trump babies mad. 
SHIBUSD
Dragonman1 Dragonman1 32 minutes ago
I hope we all benefit from this great beer co and see the awesome results in the report coming out soon, The bashers or the fool force is in for a big wake up call, northbound we go!
KEGS
NickyCapone NickyCapone 36 minutes ago
Warning‼️
All Shorties‼️

Last One Out is a Rotten Egg‼️
AMC
lakers17 lakers17 41 minutes ago
Yeah I feel the same way recently. Both the OTC and crypto are pissing me off. I keep buying more and more crypto on many of these dips. It's really boom or bust for me.
Guzzi62 Guzzi62 44 minutes ago
The main trial didn't fail dude, one primary endpoint failed, which is not the same.

That endpoint is in the process of being removed by the FDA which you likely knew already.

Why are you lying?
AVXL
king_kong king_kong 47 minutes ago
https://x.com/maxinvestor89/status/1891752794396229705?s=46&t=He3ILIizDMal7FFXIIgFjw
EEGI
sharkey1 sharkey1 49 minutes ago
Correction, on the house bill 1396, copied from redit,

https://www.reddit.com/r/WallStreetbetsELITE/comments/1irl3m7/how_hr1396_could_impact_the_stock_market_generic/

can't find on google, it's in the ways and means committee
I think
ELTP
capgain capgain 50 minutes ago
Good morning, Larry, the cold is returning again.
walterc walterc 51 minutes ago
mailconversation with IR
read the reply
- Appreciate your patience as we've worked to get you answers to some of these questions. Management is not in a position to provide an update on the commercial strategy with firm targets, timelines, etc. as that would constitute a material upda
LWLG
valleybenedetto valleybenedetto 51 minutes ago
There is ZERO dilution here. No warrants no overhead supply. 
SRM
capgain capgain 51 minutes ago
Happy Birthday, B2B!
DJPele DJPele 53 minutes ago
Interesting update on the biosimilar candidate FYB206 with Merck's Keytruda:

"Regulatory developments in the U.S. indicate that the framework conditions for biosimilars continue to improve. The FDA has confirmed that extensive analytical data, together with the ongoing phase I trial,
MRK NWBO
SkeBallLarry SkeBallLarry 53 minutes ago
*Super* " Happy BirthDay, back2basics " ..!!
NickyCapone NickyCapone 54 minutes ago
Shortie is DOOMED‼️

Rude Awaking‼️

MOASS Alert 🚨 ‼️

Ring the Bell 🛎️ ‼️
AMC